NEW YORK (GenomeWeb News) – Olink Bioscience today said that Abnova will distribute the firm's Duolink in situ PLATM product line in the US.

The agreement expands a previous pact between the firms, under which they agreed to co-develop and co-market hundreds of target-specific assays for studies of protein phosphorylation and protein interactions based on antibodies from Abnova and the Duolink product line.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.